Resistance in Europe

TITLE: HIV-1 drug resistance in Europe: challenges and perspectives


DEADLINE: END OF FEBRUARY
AUTHORS: Ana Abecasis & Andrea Pineda - Ravindra Gupta or Carlo Torti -  Ricardo Camacho, Kristof Theys,

FOCUS: GENERICS AND RESISTANCE, INCREASE SUBTYPE C AND RESISTANCE, IMPACT OF TDR IN FIRST LINE THERAPY, NEW DRUGS AND RESISTANCE....
("Drug Resistance"[Mesh]) AND "HIV"[Mesh] AND "drugs"[Mesh]


WORD COUNT: 2000 WORDS

Search on 2011 - 2015 -2016 papers

Figures: what figure or table do we want? 


1. Introduction: HIV, some general info and how resistance is generated

+ NGS? 

Resistance:  potency (short term) times genetic barrier (long term), but adherence (toxicity and tolerability)    ~~~ evoluti